Browse Category

Investment Analysis News 12 December 2025

USA Rare Earth (USAR) Stock News Today: Round Top Timeline Acceleration, Russell 2000 Catalyst, and Analyst Forecasts (Dec. 12, 2025)

USA Rare Earth (USAR) Stock News Today: Round Top Timeline Acceleration, Russell 2000 Catalyst, and Analyst Forecasts (Dec. 12, 2025)

USA Rare Earth, Inc. (NASDAQ: USAR ) is back in focus on Friday, December 12, 2025 , after a fast-moving week that combined company-specific catalysts (a pulled-forward production timeline at its Round Top project), upcoming index inclusion (Russell 2000/3000), and
BitMine Immersion Technologies (BMNR) Stock: Latest News, Analyst Forecasts, and What’s Driving the Ethereum-Treasury Trade (Dec. 12, 2025)

BitMine Immersion Technologies (BMNR) Stock: Latest News, Analyst Forecasts, and What’s Driving the Ethereum-Treasury Trade (Dec. 12, 2025)

Updated: Friday, December 12, 2025 BitMine Immersion Technologies, Inc. (NYSE American: BMNR) has become one of the market’s most closely watched—and most volatile—crypto-linked equities, largely because it now functions less like a traditional operating company and more like an Ethereum-heavy
Lam Research Corporation Stock (LRCX) News, Forecasts & Analyst Outlook for Dec. 12, 2025: AI Chip Equipment Demand Meets New Competitive and Policy Risks

Lam Research Corporation Stock (LRCX) News, Forecasts & Analyst Outlook for Dec. 12, 2025: AI Chip Equipment Demand Meets New Competitive and Policy Risks

Lam Research Corporation (NASDAQ: LRCX) is ending the week near record territory after a powerful run that pushed the semiconductor equipment name back into the spotlight. On Friday, Dec. 12, 2025, shares dipped modestly in early trading as investors balanced
Fiserv Stock News Today (Dec. 12, 2025): FISV Trades Near $69 as Security Lawsuit Headlines, Analyst Targets, and 2026 “Show-Me” Year Shape the Outlook

Fiserv Stock News Today (Dec. 12, 2025): FISV Trades Near $69 as Security Lawsuit Headlines, Analyst Targets, and 2026 “Show-Me” Year Shape the Outlook

Fiserv, Inc. stock is back in the spotlight on December 12, 2025, as investors weigh fresh cybersecurity-related lawsuit headlines, ongoing securities class-action reminders, and a still-evolving turnaround narrative following the company’s dramatic Q3 guidance reset and leadership shake-up in late
Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Updated: December 12, 2025Company: Milestone Pharmaceuticals Inc. ( NASDAQ: MIST ) Milestone Pharmaceuticals Inc. stock is drawing heightened attention on December 12, 2025 , as investors position ahead of a make-or-break FDA decision for the company’s lead program, CARDAMYST™ (etripamil)
1 123 124 125 126 127 230
Go toTop